Jaguar Health to launch Neonorm Dog digestive health product By Investing.com

Jaguar Health, Inc. announced the upcoming launch of Neonorm Dog, a plant-based, non-prescription product designed to support canine digestive health. This new product expands their existing Neonorm franchise, as the company navigates financial challenges including shares trading near a 52-week low and recent underwhelming financial results. Jaguar Health is also working towards full FDA approval for Canalevia-CA1 and has plans for a reverse stock split to meet Nasdaq’s minimum bid price requirement.

GRPN8.39%
BASED-12.11%
LOW-4.04%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned